| Literature DB >> 19020868 |
Thelma Schilt1, Anneke E Goudriaan, Maarten W Koeter, Wim van den Brink, Ben Schmand.
Abstract
RATIONALE: Ecstasy (+/-3,4-methylenedioxymethamphetamine) is a widely used recreational drug that may damage the serotonin system and may entail neuropsychological dysfunctions. Few studies investigated predictors for ecstasy use. Self-reported impulsivity does not predict the initiation of ecstasy use; the question is if neuropsychological indicators of impulsivity can predict first ecstasy use.Entities:
Mesh:
Substances:
Year: 2008 PMID: 19020868 PMCID: PMC2761546 DOI: 10.1007/s00213-008-1398-y
Source DB: PubMed Journal: Psychopharmacology (Berl) ISSN: 0033-3158 Impact factor: 4.530
Characteristics of demographics and substance use (N = 149)
| Future ecstasy users ( | Persistent ecstasy-naives ( | ||
|---|---|---|---|
| Gender (M/F%) | 25 M, 34 F (42/58%) | 38 M, 52 F (42/58%) | 0.99a |
| Age | 21.4 ± 2.8 | 21.7 ± 2.5 | 0.58b |
| DART-IQ | 104.1 ± 9.2 | 105.2 ± 9.5 | 0.47b |
| BDI | 3.9 ± 3.8 | 3.2 ± 3.3 | 0.21b |
| Alcohol (units/week) | 9.1 ± 7.5 | 9.0 ± 9.0 | 0.66c |
| Tobacco (cigarettes/week) | 34.1 ± 49.2 | 26.7 ± 52.0 | 0.07c |
| Cannabis (joints last year) | 36.8 ± 64.8 | 19.4 ± 37.6 | 0.09c |
| Amphetamine (times last year) | 0.0 ± 0.0 | 0.6 ± 5.5 | 0.42c |
| Cocaine (times last year) | 1.0 ± 2.3 | 0.5 ± 1.6 | 0.09c |
Values expressed as mean ± SD
aPearson chi-square
bANOVA
cMann–Whitney
Fig. 1Total advantageous deck choices of future ecstasy versus persistent ecstasy naives. Error bars depict standard errors of the mean
Fig. 2Mean reaction times (ms) after wins and after losses of future ecstasy versus persistent ecstasy-naives. Error bars represent standard errors of the mean
Prediction of IGT performance and difference in reaction time after IGT wins and losses (dRT) on future first ecstasy use
| SE | Wald statistics | OR | 95% CI | |||
|---|---|---|---|---|---|---|
| DART-IQ | −0.01 | 0.02 | 0.14 | 0.71 | 0.99 | 0.95–1.03 |
| Sex | −5.19 | 1.70 | 9.35 | 0.00 | 0.01 | 0.00–0.16 |
| Cannabis (joints last year)a | 0.17 | 0.11 | 2.26 | 0.13 | 1.18 | 0.95–1.48 |
| Cocaine (use/no use last year) | 1.12 | 0.65 | 2.96 | 0.09 | 3.08 | 0.86–11.06 |
| Alcohol (units/week)a | −0.09 | 0.22 | 0.15 | 0.70 | 0.92 | 0.60–1.41 |
| Tobacco (cigarettes/week)a | 0.04 | 0.09 | 0.20 | 0.65 | 1.04 | 0.88–1.24 |
| IGT performance | −0.06 | 0.03 | 5.24 | 0.02 | 0.94 | 0.90–0.99 |
| IGT performance × sex | 0.11 | 0.04 | 9.19 | 0.00 | 1.11 | 1.04–1.20 |
| dRT | −0.00 | 0.00 | 5.59 | 0.02 | 0.99 | 0.99–1.00 |
OR odds ratio, CI confidence interval
aLog-transformed